Is gardasil vaccine safe in pregnancy?
Reading File
Searching for evidence on Gardasil (HPV vaccine) safety in pregnancy.
search_medical_text
Gardasil HPV vaccine safety pregnancy
Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
Page 343
search_medical_text
HPV vaccine pregnancy outcomes fetal risk inadvertent exposure
Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
Page 322
GradeResponse
GradeResponse
Gardasil (HPV Vaccine) Safety in Pregnancy
Official Recommendation
Gardasil (including Gardasil 9) is not recommended during pregnancy due to limited safety data. This is a precautionary stance, not a contraindication based on demonstrated harm (rated CIII — expert opinion, limited data).
What the Evidence Actually Shows
Despite the recommendation against use, available data are reassuring:
| Study / Source | Finding |
|---|---|
| Combined analysis of 5 RCTs (HPV 6/11/16/18 quadrivalent vaccine) | Vaccine administration during pregnancy did not negatively affect pregnancy outcomes |
| Denmark population-based study (~5,200 pregnancies, quadrivalent vaccine) | No increased risk of spontaneous abortion, stillbirth, or infant mortality |
| Denmark Medical Birth Register (1,665 exposed pregnancies) | No significantly increased risk of major birth defects, preterm birth, or low birth weight |
| 9-valent (Gardasil 9) data | More limited but also reassuring to date |
(Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV, pp. 322, 343)
Key Clinical Points
- Pregnancy testing is not required before vaccination.
- If inadvertently given during pregnancy, no intervention is needed — simply defer any remaining doses until after delivery.
- The vaccine series should be paused and completed postpartum.
- The recommendation against use is precautionary, not because harm has been demonstrated.
Bottom Line
Gardasil is not approved for use in pregnancy, but inadvertent exposure carries no known fetal risk based on current evidence. Any remaining doses in a series should be deferred until after delivery. Women who receive a dose before realizing they are pregnant can be reassured that studies have not shown adverse pregnancy outcomes.
This is a shared conversation. Sign in to Orris to start your own chat.